SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-090230
Filing Date
2023-11-27
Accepted
2023-11-27 16:15:46
Documents
54
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0923_10xcapital3.htm   iXBRL 10-Q 812957
2 CERTIFICATION f10q0923ex31-1_10xcapital3.htm EX-31.1 9799
3 CERTIFICATION f10q0923ex31-2_10xcapital3.htm EX-31.2 9065
4 CERTIFICATION f10q0923ex32-1_10xcapital3.htm EX-32.1 3936
5 CERTIFICATION f10q0923ex32-2_10xcapital3.htm EX-32.2 4056
  Complete submission text file 0001213900-23-090230.txt   4462897

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE vcxb-20230930.xsd EX-101.SCH 49502
7 XBRL CALCULATION FILE vcxb-20230930_cal.xml EX-101.CAL 22180
8 XBRL DEFINITION FILE vcxb-20230930_def.xml EX-101.DEF 219966
9 XBRL LABEL FILE vcxb-20230930_lab.xml EX-101.LAB 395206
10 XBRL PRESENTATION FILE vcxb-20230930_pre.xml EX-101.PRE 229843
48 EXTRACTED XBRL INSTANCE DOCUMENT f10q0923_10xcapital3_htm.xml XML 533026
Mailing Address 1 WORLD TRADE CENTER FLOOR 85 NEW YORK NY 10007
Business Address 1 WORLD TRADE CENTER FLOOR 85 NEW YORK NY 10007 (212) 257-0069
10X Capital Venture Acquisition Corp. III (Filer) CIK: 0001848948 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41216 | Film No.: 231440424
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences